Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2627 (LINC02627)

Target
LINC02627
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2627 (LINC02627) is a member of the lincRNA subclass of long non-coding RNAs, defined by their intergenic location and lack of coding potential. LincRNAs, including LINC02627, are transcribed RNA molecules larger than 200 nucleotides that do not encode proteins but can be involved in the regulation of gene expression, chromatin organization, and potentially other aspects of genome function in a tissue- and context-dependent manner. While many lincRNAs have been implicated in fine-tuning gene expression or acting as scaffolds for chromatin-modifying complexes, the specific biological function and disease associations of LINC02627 are currently not well characterized in the literature. Unlike "classical" drug targets, LINC02627 is not established as a therapeutic receptor, enzyme, transporter, or signaling molecule.

02

Biological functions

Gene regulation (potential based on lincRNA family properties)Chromatin remodeling and transcriptional regulation (general for lincRNAs)
03

Disease associations

Other (No direct evidence links LINC02627 to specific diseases as of now; lincRNAs in general may be involved in cancer and cell cycle regulation, but this is not confirmed for LINC02627)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2627 (LINC02627).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2627 (LINC02627).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call